Digoxin and Reduction of Heart Failure Hospitalization in Chronic Systolic and Diastolic Heart Failure

In the Digitalis Investigation Group trial, digoxin-associated reduction in the combined end point of heart failure (HF) hospitalization or HF mortality was significant in systolic but not in diastolic HF. To assess whether this apparent disparity can be explained by differences in baseline characte...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Meyer, Philippe, White, Michel, Mujib, Marjan, Nozza, Anna, Love, Thomas E., Aban, Inmaculada, Young, James B., Wehrmacher, William H., Ahmed, Ali
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2633091/
https://ncbi.nlm.nih.gov/pubmed/19064024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2008.05.068
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller